Growing Little PEAPODS Study

Part of paid clinical trials in Madison, Wisconsin.

Sponsor
University of Wisconsin, Madison
Study ID
NCT06226051
Status
Recruiting
Apply to this trial

Conditions

  • Intrauterine Growth Restriction
  • Premature
  • Premature Birth
  • Premature Infant
  • Small for Gestational Age at Delivery

Eligibility Criteria

Sex
ALL
Age
22 Weeks - 32 Weeks
Healthy Volunteers
Not accepted

Interventions

  • PEAPOD Infant Body Composition measuring device — DEVICE
    PEAPOD is a device to that collects body composition measurements.

Study Details

The goal of this clinical trial is to learn more about how the food and nutrition babies receive while in the Neonatal Intensive Care Unit (NICU) influences their ability to gain weight and fat-free mass, and their future growth and development. Participants will: * have body growth measurements collected using the PEAPOD device * have nutritional information collected, and * be followed for neurodevelopmental outcomes Participants can expect to be in the study for 36 months.

Key Dates

Start date
Sep 4, 2024
Status verified
Aug 2025
Primary completion
Jan 31, 2028
Completion
Jan 31, 2028

Study Design

Enrollment
120 participants (estimated)

Arms

  • Arm: PEAPOD device
    Premature babies will be evaluated using the PEAPOD Infant Body Composition measuring device

Primary Outcome Measure

To evaluate the correlation between nutritional intake over the first two weeks of life and the percent increase in fat-free mass measured by the PEAPOD [ Time Frame: Birth to 2 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Meriter Hospital, Inc.MadisonWisconsin53715-

Find similar trials in Madison, WI

By research site
Meriter Hospital, Inc.· Madison, WI

Related Studies